Original Article
The immune system operates through a tightly timed orchestration of attack and repair. Inflammation embodies this duality it is both a necessary defense and, if unchecked, a driver of pathology. While individual cytokine biology is well established, the dynamic transition between a pro‑inflammatory “alarm” phase and a regulatory “resolution” phase remains underappreciated. We investigated cytokine kinetics using two complementary models: standardized murine inflammation and primary human peripheral blood mononuclear cells (PBMCs), both stimulated with ovalbumin (the specified “antigen X”) [1,2]. Interleukin‑6 (IL‑6) and tumor necrosis factor‑alpha (TNF‑α) surged within six hours, marking the alarm phase, followed by expansion of CD25⁺FoxP3⁺ regulatory T cells (Tregs) and increased interleukin‑10 (IL‑10) and transforming growth factor‑beta (TGF‑β) at 48–72 hours. In Treg‑deficient models, resolution failed and fibrosis ensued. Mirrored kinetics in human PBMCs suggest an evolutionarily conserved mechanism. These findings emphasize that immune success depends not on unrestrained strength but on timely restraint, indicating that therapeutics should modulate this rhythm rather than suppress it outright.
Loading publication timeline...